Experimental Arguments For Rational Use of Spiramycin (Embonate) Against Respiratory Infections in Calves

Authors

  • Rémi Lescene Union Laitière Normande 50890 CONDE-sur-VIRE (France)
  • Jacques Poirier Rhône-Poulenc Animal Nutrition, 20, Avenue Rayrrwnd Aron 92165 ANTONY (France)
  • Alain Richard Rhône-Poulenc Animal Nutrition, 20, Avenue Rayrrwnd Aron 92165 ANTONY (France)

DOI:

https://doi.org/10.21423/aabppro19926613

Keywords:

respiratory diseases, veal calf, therapeutic treatment, spiramycin, macrolid antibiotic

Abstract

Respiratory diseases represent the main cause of morbidity and mortality in veal calf production. Viruses (PI3, RSV, ... ), bacteria (Pasteurella spp., Haemophilus somnus, ...) and mycoplasma (M. bovis) are the main causative agents of such infections. Therapeutic treatment remains based upon the administration of antibiotics in order to limit bacterial and mycoplasmal surinfections.

The purpose of the studies described hereafter was to demonstrate the marked affinity of spiramycin for tissues and, consequently, the efficacy of this macrolid antibiotic in the treatment of respiratory diseases in calves.

Cover image of the Third Volume of the 25th Conference Proceedings: An earl-morning photo of farmland. A small farm is nestled among rolling hills, fields stretching across a curving road that disappears between dark green trees. The barn is a cheery red color with a tin roof. Beneath the photo is the a statement of the conference's theme in white italics: Challenges of the Bovine Industry in the Twenty-First Century. Deep red background.

Downloads

Published

1992-08-31

Issue

1992: Volume 3

Section

Respiratory Disease